HSV shedding.
Sacks
S L
SL
Viridae, Vancouver, Canada.
Griffiths
P D
PD
Corey
L
L
Cohen
C
C
Cunningham
A
A
Dusheiko
G M
GM
Self
S
S
Spruance
S
S
Stanberry
L R
LR
Wald
A
A
Whitley
R J
RJ
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D004279:DNA, Viral / Q000032:analysis; D006558:Herpes Genitalis / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission* / Q000821:virology*; D006561:Herpes Simplex / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission / Q000821:virology*; D018259:Herpesvirus 1, Human / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology; D018258:Herpesvirus 2, Human / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology; D006801:Humans; D016133:Polymerase Chain Reaction; D018139:Simplexvirus / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology*; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D017201:Virus Shedding
D000998:Antiviral Agents; D004279:DNA, Viral; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir